Limba
|
Lifirafenib (BGB-283, Beigene-283) potently inhibits RAFfamily kinases and EGFRactivities in biochemical assays with IC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.
Price | 992,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Lifirafenib (BGB-283, Beigene-283) potently inhibits RAFfamily kinases and EGFRactivities in biochemical assays with IC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant. |